BioScience Health Innovations, Inc. Income Statement
BHIC|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
BioScience Health Innovations, Inc. reported $6M in revenue and $642,090 in net income for FY2025. Revenue has grown at a 334.5% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 7.48 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.7M | $1.8M | $597.6K | $69.3K | $0 | $0 |
| Cost of Revenue | $2.4M | $536.1K | $113.2K | $9.7K | - | - |
| Gross Profit | $3.2M | $1.3M | $484.4K | $59.6K | - | - |
| SG&A Expense | $2.2M | $1.1M | $706.3K | $151.3K | $25.6K | $7.7K |
| R&D Expense | $161.4K | $25.9K | $0 | - | - | - |
| Operating Income | $719.1K | $87.0K | -$251.5K | -$170.4K | -$25.6K | -$7.7K |
| Interest Expense | - | - | - | - | $450 | - |
| Income Tax | $77.0K | $0 | $0 | $0 | $0 | $0 |
| Net Income | $642.1K | $87.0K | -$251.5K | -$170.4K | -$25.6K | -$7.7K |
| EPS (Basic) | $0.01 | -$0.01 | - | - | - | - |
| EPS (Diluted) | $0.01 | -$0.01 | - | - | $0.00 | $0.00 |
| Shares Outstanding | 11.0M | 40.9M | 5.5M | 5.5M | 5.5M | 2.8M |
| Gross Margin | 57.0% | 70.9% | 81.1% | 86.0% | - | - |
| Operating Margin | 12.6% | 4.7% | -42.1% | -245.8% | - | - |
| Profit Margin | 11.3% | 4.7% | -42.1% | -245.8% | - | - |